| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8213490 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 9 Pages |
Abstract
Cisplatin can be safely delivered with 5-FU-based chemoradiation therapy. Acute toxicity was acceptable, and patient-reported QOL showed the regimen was tolerable. Outcomes are encouraging and justify further study of this regimen.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Rebecca B. MBChB, Helen MBChB, MD, Bethany MSc, Amit MD, Lillian L. MD, John MD, Rebecca K.S. MBChB, MSc, Eric MD, Carol MD, Jennifer MD, Zahra MBBS, MSc, Bernard MBChB, Ron MD, David MD, Geoffrey MD, Monika K. MD, Robert MD, MSc, Anthony M. MD, CM, PhD,